Sapidyne was founded in 1995 by co-inventors Steve Lackie & Tom Glass. Early instruments were placed at research labs such as Xavier University, the United States Army, and the Environmental Protection Agency. Their work helped to showcase the advantages of KinExA technology. Through this early work, and the many collaborations since, KinExA technology has become a popular tool for measuring binding interactions in top pharmaceutical and biotechnology companies along with many universities and research labs.
Sapidyne is now operating worldwide with its headquarters in Boise, Idaho, an office in Hannover, Germany and distributors in China, Singapore, and Japan. The founders continue to advance KinExA technology by developing unique applications and inventing new instrumentation that progresses the industry. As the company continues to grow, we still maintain an emphasis on support and learning from our customers. The outcome is continuous growth in our understanding of binding and continued improvement in our measurement tools. With over 20 years of experience, we are confident our technology is right for your affinity, kinetic, and concentration measurements.
Sapidyne is now operating worldwide with its headquarters in Boise, Idaho, an office in Hannover, Germany and distributors in China, Singapore, and Japan. The founders continue to advance KinExA technology by developing unique applications and inventing new instrumentation that progresses the industry. As the company continues to grow, we still maintain an emphasis on support and learning from our customers. The outcome is continuous growth in our understanding of binding and continued improvement in our measurement tools. With over 20 years of experience, we are confident our technology is right for your affinity, kinetic, and concentration measurements.
